Understanding COVID-Associated Coagulopathy
Interview with Ariela Marshall, M.D. In this bonus episode of Lab Medicine Rounds, Dr. Ariela Marshall, Associate Professor of Medicine in the Division of Hematology at Mayo Clinic, discusses COVID-associated coagulopathy. Dr. Marshall will discuss this
Lab Medicine Rounds · Mayo Clinic Laboratories
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Time Stamps
00:00 Podcast Intro
00:40 What is COVID-associated coagulopathy and why is it important to recognize this?
02:45 How is this coagulopathy similar to or different from other coagulopathies that we commonly see in clinical practice?
04:30 Is there recommended testing for COVID-associated coagulopathy?
06:30 Can you explain what the soluble fibrin monomer test is?
08:09 How is COVID-associated coagulopathy managed in terms on prophylactic anticoagulation, therapeutic anticoagulation, and prophylactic transfusion?
14:23 What are a few lessons that you have learned during this pandemic so far?
Resources:
1. F.A. Klok, M.J.H.A. Kruip, N.J.M. van der Meer, et al., Incidence of thrombotic complications in critically ill ICU patients with COVID-19,Thrombosis Research (2020), https://doi.org/10.1016/j.thromres.2020.04.013